Lawmakers urge no delays for biosimilars Vermont AG investigating generic drug price spikes CHPA commends administration for signing DASCA into law FDA approves supplemental new drug application for the use of Kalydeco Report: Office of Generic Drugs pledges to take action on ANDA backlog FDA approves Saxenda from Novo Nordisk FDA approves sBLA for Genentech's Gazyva U.S. Senate Special Committee on Aging advocates increased generic utilization NYT: Health care is a hardship for many Americans FDA approves Xtoro from Alcon Labs First Previous 78 79 80 81 82 Next Last
